Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
OBIO
OBIO | US
4.13
USD-0.02
-0.48%
OBIO | US
Loading StockChartView...
About OBIO
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
4.13
Open
4.14
High
4.22
Low
4.00
Orchestra BioMed Holdings Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions. The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings Inc. is based in New Hope Pennsylvania.
View LessOBIO | US
Risk
45.1
Sharpe
0.51
Luna's Score
40/100
Recommendation
Sell
Luna says (OBIO | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
48.7%1 month
45.1%3 months
63.7%6 months
69.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.85
Debt to equity
0.03
Debt to assets
0.02
Ent. to EBITDA
-1.81
Ent. to rev.
72.32
PEG
-
Other Fundamentals
EBITDA
-58.00M
MarketCap
156.22M
MarketCap(USD)
156.22M
Div. yield
-
Op. margin
-2.17K
Erngs. growth
-
Rev. growth
-15.00
Ret. on equity
-83.22
Short ratio
13.30
Short perc.
4.30
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.71
Range1M
0.82
Range3M
1.43
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.88
Price X volume
1.04M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.81 | 0.53 | Cheaper |
| Ent. to Revenue | 72.32 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 4.85 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 63.75 | 72.80 | Par |
| Debt to Equity | 0.03 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 156.22M | 3.66B | Emerging |
